Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  1973-07-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.7164/ANTIBIOTICS.26.412PMID 4782059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Letter: Kanamycin phosphotransferase. I. Mechanism of cross resistance between kanamycin and lividomycin.

  1973cited by this paper
• BB-K 8, a new semisynthetic aminoglycoside antibiotic.

  1972cited by this paper
• A new enzyme in Escherichia coli carrying R-factor phosphorylating 3'-hydroxyl of butirosin A, kanamycin, neamine and ribostamycin.

  1972cited by this paper
• Inactivation of 3',4'-dideoxykanamycin B by an enzyme solution of resistant E. coli and isolation of 3',4'-dideoxykanamycin B 2''-guanylate and 2''-inosinate.

  1972cited by this paper
• Studies on Aminosugars. XXXII. Synthesis of 3′, 4′-Dideoxykanamycin B

  1972cited by this paper
• The structure determination of an enzymatic inactivation product of 3',4'-dideoxykanamycin B.

  1971cited by this paper
• 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.

  1971cited by this paper
• Butirosins A and B, aminoglycoside antibiotics. I. Structural units

  1971cited by this paper
• Adenylyldideoxykanamycin B, a product of the inactivation of dideoxykanamycin B by Escherichia coli carrying R factor.

  1971cited by this paper
• Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor.

  1967cited by this paper
• Studies of Aminosugars. XI. Configurational Studies of Aminosugar Glycosides and Aminocyclitols by a Copper Complex Method

  1966cited by this paper

• Natural product inspired antibiotics approved for human use - 1943 to 2025.

  2025cites this paper
• Direct visualization of ribosomes in the cell-free system revealed the functional evolution of aminoglycoside.

  2024cites this paper
• Ribosomal a site binding pattern differs between arm methyltransferases from clinical pathogens and a natural producer of aminoglycosides.

  2024cites this paper
• Potential roles of the interactions between gut microbiota and metabolites in LPS-induced intrauterine inflammation (IUI) and associated preterm birth (PTB)

  2024cites this paper
• Aprosamine Derivatives Active against Multidrug-Resistant Gram-Negative Bacteria.

  2023cites this paper
• Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions

  2023cites this paper
• Remembering Dr. Shinichi Kondo (15 June 1928–8 October 2022)

  2023cites this paper
• A mini-review: environmental and metabolic factors affecting aminoglycoside efficacy

  2022cites this paper
• A novel Ag/ZnO core-shell structure for efficient sterilization synergizing antibiotics and subsequently removing residuals

  2022cites this paper
• The Antibiotic Resistome: A Guide for the Discovery of Natural Products as Antimicrobial Agents.

  2021cites this paper
• Pyridoxal-5′-phosphate-dependent enzyme GenB3 Catalyzes C-3′,4′-dideoxygenation in gentamicin biosynthesis

  2021cites this paper
• Carbohydrate-based antibiotics: Opportunities and challenges

  2020cites this paper
• Pyridoxal-5'-Phosphate-Dependent Enzyme GenB3 1 Catalyzes C-3',4'-Dideoxygenation in Gentamicin 2 Biosynthesis

  2020cites this paper
• Crystal structure of GenB1 from Micromonospora echinospora in complex with PLP (internal aldimine)

  2019cites this paper
• Biosynthesis of Aminoglycoside Antibiotics

  2019cites this paper
• In vitro and in vivo antimicrobial activity of TS2037, a novel aminoglycoside antibiotic

  2018cites this paper
• Complete reconstitution of the diverse pathways of gentamicin B biosynthesis

  2018cites this paper
• Plasticity of Aminoglycoside Binding to Antibiotic Kinase APH(2″)-Ia

  2018cites this paper
• Overcoming Aminoglycoside Enzymatic Resistance: Design of Novel Antibiotics and Inhibitors

  2018influential citation
• Kanamycin and its derivative, arbekacin: significance and impact

  2018cites this paper
• Modulation of kanamycin B and kanamycin A biosynthesis in Streptomyces kanamyceticus via metabolic engineering

  2017cites this paper
• Discovery of 2-hydroxyarbekacin, a new aminoglycoside antibiotic with reduced nephrotoxicity

  2017cites this paper
• Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’

  2017cites this paper
• Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens.

  2016cites this paper
• Euvesperins A and B, new circumventors of arbekacin resistance in MRSA, produced by Metarhizium sp. FKI-7236

  2016cites this paper
• Paraphaeosphaeride D and berkleasmin F, new circumventors of arbekacin resistance in MRSA, produced by Paraphaeosphaeria sp. TR-022

  2016cites this paper
• Synthesis and Antiribosomal Activities of 4'-O-, 6'-O-, 4″-O-, 4',6'-O- and 4″,6″-O-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5- and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside Antibiotics.

  2015cites this paper
• Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3′-deoxykanamycin A and gentamicin B

  2015cites this paper
• Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin

  2015cites this paper
• Clinical practice guidelines for therapeutic drug monitoring of arbekacin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring.

  2014cites this paper
• Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers.

  2014cites this paper
• Crystal Structures of a Bioactive 6′‐Hydroxy Variant of Sisomicin Bound to the Bacterial and Protozoal Ribosomal Decoding Sites

  2013cites this paper
• Practice guidelines for therapeutic drug monitoring of voriconazole: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring

  2013cites this paper
• Synthesis of Aminoglycosides

  2013cites this paper
• Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance

  2013cites this paper
• Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6′)/APH(2″)

  2012cites this paper
• Construction of kanamycin B overproducing strain by genetic engineering of Streptomyces tenebrarius

  2011cites this paper
• Clinical efficacy of arbekacin for Gram-negative bacteria

  2011cites this paper
• Biosynthesis of Ribostamycin Derivatives by Reconstitution and Heterologous Expression of Required Gene Sets

  2011cites this paper
• Antibacterial to antifungal conversion of neamine aminoglycosides through alkyl modification. Strategy for reviving old drugs into agrofungicides

  2010cites this paper
• The Selective Protection of Amino Functions in Aminoglycosides: A Review of Possible Approaches

  2010cites this paper
• Structural Basis of APH(3′)-IIIa-Mediated Resistance to N1-Substituted Aminoglycoside Antibiotics

  2009cites this paper
• Dengue hemorrhagic fever in adults, an emerging problem in Thailand: a retrospective study of 75 adult dengue infection in 2007.

  2009cites this paper
• In vitro activity of arbekacin and fosfomycin against methicillin-resistant Staphylococcus aureus clinical isolates at Siriraj Hospital.

  2009cites this paper
• Studies on the conformational features of neomycin-B and its molecular recognition by RNA and bacterial defense proteins.

  2008cites this paper
• Influences of dosage regimen and co-administration of low-molecular weight proteins and basic peptides on renal accumulation of arbekacin in mice.

  2008cites this paper
• Efficacy of the Arbekacin and Teicoplanin Combination on Glycopeptide Intermediate Staphylococcus aureus in a Rabbit Model of Endocarditis

  2008cites this paper
• Chemoenzymatic acylation of aminoglycoside antibiotics.

  2008cites this paper
• NMR-based analysis of aminoglycoside recognition by the resistance enzyme ANT(4'): the pattern of OH/NH3(+) substitution determines the preferred antibiotic binding mode and is critical for drug inactivation.

  2008cites this paper
• Combined Chemical‐Enzymatic Assembly of Aminoglycoside Derivatives with N‐1‐AHB Side Chain

  2008cites this paper
• UNIVERSIDAD COMPLUTENSE DE MADRID Facultad de Ciencias Biológicas Departamento de Bioquímica y Biología Molecular I OBTENCIÓN Y CARACTERIZACIÓN BIOQUÍMICA DE UN ENZIMA DE RESISTENCIA A ANTIBIÓTICOS AMINOGLICÓSIDOS: 6-ADENILTRANSFERASA DE Bacillus subtilis

  2008influential citation
• Biosynthesis of aminocyclitol-aminoglycoside antibiotics and related compounds.

  2007cites this paper
• 7.21 – Aminoglycosides Antibiotics

  2007cites this paper
• Mechanisms of Aminoglycoside Antibiotic Resistance

  2007cites this paper
• Biosynthesis of butirosin: transfer and deprotection of the unique amino acid side chain.

  2007cites this paper
• Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.

  2007cites this paper
• Genetic studies on the biosynthesis of the major aminoglycoside antibiotics: Isolation, analysis and comparison of the biosynthetic gene clusters for 12 aminoglycoside antibiotics

  2007cites this paper
• Elaboration of Neosamine Rings in the Biosynthesis of Neomycin and Butirosin

  2007cites this paper
• Population Pharmacokinetics of Arbekacin in Patients Infected with Methicillin-Resistant Staphylococcus aureus

  2006cites this paper
• Synergy of Arbekacin-based Combinations Against Vancomycin Hetero-intermediate Staphylococcus aureus

  2006cites this paper
• Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.

  2006cites this paper
• Synthesis and antibacterial activity of novel neamine derivatives.

  2006cites this paper
• Biosynthesis of 2-deoxystreptamine-containing aminoglycoside antibiotics.

  2006cites this paper
• Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance.

  2006cites this paper
• Pharmacokinetic-Pharmacodynamic Relationship of Arbekacin for Treatment of Patients Infected with Methicillin-Resistant Staphylococcus aureus

  2006cites this paper
• Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 2: Synthesis of potent αvβ3/αIIbβ3 dual antagonists

  2006cites this paper
• Enzymatic 2'-A^-Acetylation of Arbekacin and Antibiotic Activity of Its Product1

  2006cites this paper
• THE JOURNAL OF ANTIBIOTICS GENTAMICIN ACETYLTRANSFERASE IN ESCHERICHIA COLI CARRYING R FACTOR Sir:

  2006cites this paper
• A simple structural-based approach to prevent aminoglycoside inactivation by bacterial defense proteins. Conformational restriction provides effective protection against neomycin-B nucleotidylation by ANT4.

  2005cites this paper
• Aminoglycoside Kinases and Antibiotic Resistance

  2005cites this paper
• A proof of the specificity of kanamycin-ribosomal RNA interaction with designed synthetic analogs and the antibacterial activity.

  2005cites this paper
• The ribostamycin biosynthetic gene cluster in Streptomyces ribosidificus: comparison with butirosin biosynthesis.

  2005cites this paper
• Novel Method for the Synthesis of 3′,4′‐Dideoxygenated Pyranmycin and Kanamycin Compounds, and Studies of Their Antibacterial Activity Against Aminoglycoside‐Resistant Bacteria

  2005cites this paper
• Characterization of a bifunctional aminoglycoside-modifying enzyme with novel substrate specificity and its gene from a clinical isolate of methicillin-resistant Staphylococcus aureus with high arbekacin resistance.

  2004cites this paper
• The kanamycin biosynthetic gene cluster from Streptomyces kanamyceticus.

  2004cites this paper
• Pharmacokinetics and dosing of arbekacin in preterm and term newborn infants

  2003cites this paper
• Efficacy and safety of arbekacin for staphylococcal infection in the NICU

  2003cites this paper
• Molecular mechanism for the enhancement of arbekacin resistance in a methicillin‐resistant Staphylococcus aureus

  2003cites this paper
• In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.

  2000cites this paper
• Double stage activity in aminoglycoside antibiotics.

  2000cites this paper
• Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.

  2000cites this paper
• Role of aminoglycoside 6'-acetyltransferase in a novel multiple aminoglycoside resistance of an actinomycete strain #8: inactivation of aminoglycosides with 6'-amino group except arbekacin and neomycin.

  1999cites this paper
• Aminoglycosides: Activity and Resistance

  1999cites this paper
• Enzymatic 1-N-acetylation of paromomycin by an actinomycete strain #8 with multiple aminoglycoside resistance and paromomycin sensitivity.

  1999cites this paper
• Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications

  1999cites this paper
• The Utility of Arbekacin in Patients with Methicillin-Resistant Staphylococcus aureus Infection

  1998cites this paper
• The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.

  1998cites this paper
• Straightforward synthesis of a derivative of purpurosamine C from d-galactose

  1998cites this paper
• Synthesis of 1-N-[(2S,4S)- and (2S,4R)-5-amino-4-fluoro-2-hydroxypentanoyl]dibekacins (study on structure-toxicity relationships).

  1998cites this paper
• Characterization of small colony variants of methicillin-resistantStaphylococcus aureus regrown in the presence of arbekacin

  1998cites this paper
• Pharmacokinetics and influence of arbekacin on renal function in low-birth-weight infants

  1997cites this paper
• Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?

  1997cites this paper
• Synthesis of 2″-acylamido derivatives of 2″-amino-5,2″-dideoxy-5-epi-5-fluorodibekacin and a study on the structures of 5-fluorinated dibekacin analogs by 13C NMR

  1997cites this paper
• Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.

  1997cites this paper
• Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.

  1996cites this paper
• Ototoxic Effects of 2', 3'-Dideoxy-1-N-Isoseryl Kanamycin A (ISDK) on the Inner Ear in Guinea Pigs

  1996cites this paper
• Antibacterial activity and nephrotoxicity of two novel 2″-amino derivatives of arbekacin

  1996cites this paper
• Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus

  1995cites this paper
• Arbekacin.

  1995cites this paper
• Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.

  1995cites this paper